Everpar Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$330K Sell
4,218
-460
-10% -$37.1K 0.09% 204
2026
Q1
$405K Sell
4,678
-281
-6% -$26.9K 0.14% 159
2025
Q4
$476K Sell
4,959
-1,480
-23% -$144K 0.18% 133
2025
Q3
$613K Buy
6,439
+67
+1% +$6.16K 0.24% 96
2025
Q2
$555K Buy
6,372
+85
+1% +$7.21K 0.25% 97
2025
Q1
$565K Sell
6,287
-140
-2% -$12.5K 0.3% 78
2024
Q4
$513K Buy
6,427
+228
+4% +$19.7K 0.26% 101
2024
Q3
$558K Sell
6,199
-1,054
-15% -$88.7K 0.29% 97
2024
Q2
$571K Buy
7,253
+1,416
+24% +$116K 0.29% 102
2024
Q1
$509K Sell
5,837
-781
-12% -$66.7K 0.31% 106
2023
Q4
$545K Buy
+6,618
New +$504K 0.25% 142

Other funds holding MDT

Everpar Advisors's MDT Position: Q2 2026 in Review

Everpar Advisors reduced its Medtronic (MDT) stake by 9.8% in Q2 2026, selling an estimated $37.1K and leaving 4,218 shares worth $330K. The position accounts for 0.09% of the portfolio, ranked #204.

Everpar Advisors first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $613K in Q3 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Everpar Advisors held 4,218 shares of Medtronic worth $330K as of Q2 2026.
  • Everpar Advisors sold 460 Medtronic shares in Q2 2026, an estimated $37.1K.
  • Medtronic made up 0.09% of Everpar Advisors's portfolio in Q2 2026, its #204 holding.
  • Everpar Advisors first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Everpar Advisors's Medtronic position peaked at $613K in Q3 2025.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.